Salix Wins Jury Verdict In Breach Suit Over Napo Drug
A New York state jury decided on Tuesday that Salix Pharmaceuticals Inc. met its contractual obligations in commercializing anti-diarrheal drug crofelemer and thus didn't breach a license agreement with Napo Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article